Comparative Guide
Tax
United States
Devon Bodoh, Joseph Pari, Greg Featherman & Alfonso Dulcey
Praised by clients for its ‘trial experience’ and ’technical expertise’, Weil, Gotshal & Manges LLP is a go-to firm for start-ups and leading companies across the life sciences, biotech and high-tech sectors seeking representation in high-stakes patent litigation. The team demonstrates strength in both appellate proceedings and trials, having recently won a major jury trial on behalf of Altria in a competitor patent infringement suit. Anish Desai and Elizabeth Stotland Weiswasser departed in December 2024.
L'éditorial du Legal 500
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘Trial experience. Technical expertise. High level of competence.'
‘Edward Reines and Anne Cappella have deep patent expertise.'
‘Adrian Percer; excellent patent litigation partner who dives deep, can easily pick up extremely complex technology and apply the law to it, and who has impeccable client management skill for executives. ’
Clients clés
- Regeneron Pharmaceuticals, Inc.
- Altria Group, Inc.
- LiquidPower Specialty Products Inc.
- Daiichi Sankyo
- Nuance Communications, Inc.
- Bio-Rad Laboratories
- Synthego Corporation
- Nautilus Biotechnology
- HP Inc.
- CareDx
- NeoGenomics Laboratories, Inc.
- Comcast Cable Communications, LLC
Points forts
Secured significant appellate victories for biologics innovator Regeneron Pharmaceuticals in a patent/antitrust dispute regarding its >$10B eye treatment franchise.
Sealed a win for Nuance Communications in the Federal Circuit in a patent dispute over AIenabled 3D medical imaging technology.
Representing Synthego in a Federal Circuit appeal of a PTAB decision Weil secured that decisively invalidated two competitor patents (including all 63 claims in those patents) that that were asserted against our client, a CRISPR-focused synthetic biology company, and the CRISPR community more broadly.
Autres avocats clés
Anne Capella; Adrian Percer